MENU
+Compare
ABP
Stock ticker: NASDAQ
AS OF
Jun 26, 04:59 PM (EDT)
Price
$0.23
Change
+$0.01 (+4.55%)
Capitalization
13.19M

ABP Abpro Holdings Inc Forecast, Technical & Fundamental Analysis

Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases... Show more

ABP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ABP with price predictions
Jun 25, 2025

ABP's Stochastic Oscillator stays in oversold zone for 6 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where ABP advanced for three days, in of 54 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 24, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ABP as a result. In of 42 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

ABP moved below its 50-day moving average on June 11, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ABP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (16.539). P/E Ratio (0.000) is within average values for comparable stocks, (59.016). ABP's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.300). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (60.606) is also within normal values, averaging (255.605).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ABP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ABP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ABP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ENGN3.260.27
+9.03%
enGene Holdings
SLE4.350.16
+3.82%
Super League Enterprise Inc
FLEX49.021.11
+2.32%
Flex Ltd
TBBB27.200.53
+1.99%
BBB Foods
XERS4.710.05
+1.07%
Xeris Biopharma Holdings

ABP and Stocks

Correlation & Price change

A.I.dvisor tells us that ABP and NGNE have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ABP and NGNE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABP
1D Price
Change %
ABP100%
+1.88%
NGNE - ABP
33%
Poorly correlated
-1.86%
FBIO - ABP
30%
Poorly correlated
+0.56%
QSI - ABP
25%
Poorly correlated
+7.45%
SCPH - ABP
24%
Poorly correlated
+0.25%
MNKD - ABP
24%
Poorly correlated
-3.51%
More